Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Kidney Disease: early-phase trial registry
13 of 24 indexed Diabetic Kidney Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #686 of 28,707 conditions by registered trial count.
24 US clinical trials · 13 currently recruiting · #686 of 28,707 conditions by registered trial count
Diabetic Kidney Disease: 24 US clinical trials tracked, 13 recruiting.
Diabetic Kidney Disease is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 6 of these trials.
Enrollment posture brief
Registry condition diabetic-kidney-disease
OPEN 13 | RECR 54% | LATE 3 | EARLY 12 | RANK #686 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Bulimia Nervosa (54% recruiting · 24 trials)
Diabetic Kidney Disease lists 13 open slots (54% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Kidney Disease is recruiting above its size-band peers.
13 of 24 indexed trials (54.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Diabetic Kidney Disease research.
University of Colorado, Denver accounts for 6 of 24 trials (25%). 15 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Kidney Disease enrolment sits around 103 participants.
Median target enrolment is 103 among the 24 trials that report a genuine target (sentinel values excluded). 10 of those (41.7%) plan for fewer than 100 participants.
-
Diabetic Kidney Disease splits between interventional and observational designs.
15 interventional and 9 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
24 total, page 1 of 1
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00342927
Real World Evidence Clinical Utility Study of KidneyIntelX
Renalytix AI
NCT04802395
Decision Impact Trial of KidneyIntelX
Renalytix AI
NCT04791358
NAD Augmentation in Diabetes Kidney Disease
Brigham and Women's Hospital
NCT05759468
Formoterol in Diabetes
Medical University of South Carolina
NCT07022418
Dosimetry of Tc-99m-Tilmanocept
University of California, San Diego
NCT05241522
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
University of Colorado, Denver
NCT05319990
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Petter Bjornstad
NCT05008276
A Long-Term Follow-Up Study of Participants Exposed to REACT
Prokidney
NCT05918523
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
Kalie Tommerdahl
NCT05065372
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
University of Washington
NCT05822609
Renal Mechanism of SGLT2 Inhibition
University of Colorado, Denver
NCT05507892
Mechanism of SGLT2 Inhibition in the Kidney
University of Michigan
NCT06291155
Pentoxifylline in Diabetic Kidney Disease
VA Office of Research and Development
NCT03625648
Prospective Decision Impact Trial of KidneyIntelX
Renalytix AI
NCT04960514
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Renalytix AI
NCT05198284
Atrasentan in Patients With Proteinuric Glomerular Diseases
Novartis Pharmaceuticals
NCT04573920
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
University of Colorado, Denver
NCT03945747
Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease
Inversago Pharma
NCT05514548
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
Eli Lilly and Company
NCT01683409
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
University of Colorado, Denver
NCT02502071
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
University of Colorado, Denver
NCT03620773
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
University of Washington
NCT00552409
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
University of Colorado, Denver
NCT03878277
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 9 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Kidney Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Kidney Disease page
24 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Diabetic Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Colorado, Denver sponsors the most Diabetic Kidney Disease trials on record, review their full trial history before evaluating a specific study. See University of Colorado, Denver's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Kidney Disease condition card totals 24 registered trials; most-linked intervention Placebo; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.